1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Pharmaceutical Analysis & Statistics in Norway, May 2016

Pharmaceutical Analysis & Statistics in Norway, May 2016

1-30 of 42 reports

Purchase Reports From Reputable Market Research Publishers

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

2016-2020 Norway Clinical Chemistry and Immunodiagnostic Markets: Volume and Sales Forecasts for 100 Routine and Special Chemistries, Drugs of Abuse, Endocrine Function, Immunoproteins, Therapeutic Drug Monitoring (TDM), and Tumor Marker Tests--Emerging O

  • € 1 960
  • Industry report
  • May 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the clinical chemistry and immunodiagnostic ...

  • Industries : Drug and Medication
  • Countries : Norway
IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

IMS Pharmaceutical Pricing & Reimbursement Concise Guide: Norway

  • € 1 288
  • Industry report
  • March 2016
  • by IMS Health

The Pharmaceutical Pricing & Reimbursement Concise Guides are established as the definitive reference and training text for P&R professionals around the world, drawing on the long-standing expertise of ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Norway Pharmaceuticals and Healthcare Report Q2 2016

Norway Pharmaceuticals and Healthcare Report Q2 2016

  • € 985
  • Industry report
  • April 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Pronova BioPharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical, Investment Banking
  • Countries : United Kingdom, United States, Norway
Algeta ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Algeta ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway, United Kingdom
NorDiag ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

NorDiag ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Diagnostics, Diagnostics
  • Countries : Norway, United Kingdom
DiaGenic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

DiaGenic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : Norway
Aqualis ASA (formerly Clavis Pharma ASA) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Aqualis ASA (formerly Clavis Pharma ASA) – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Investment Banking
  • Countries : Norway
KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

KAEL Co., Ltd. – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : Norway, South Korea
Nattopharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Nattopharma ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Countries : United Kingdom, Norway
Navamedic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Navamedic ASA – Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • € 280
  • Company report
  • March 2016
  • by MarketLine

Project Synopsis: Datamonitor's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Pharmaceutical
  • Countries : United Kingdom, Norway
Photocure ASA

Photocure ASA

  • € 79
  • Company report
  • May 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Photocure ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Hospitality, Hospitality
  • Countries : Norway
Nattopharma ASA

Nattopharma ASA

  • € 79
  • Company report
  • April 2016
  • by Wright Investors' Service

A textual analysis of the financial results for Nattopharma ASA compared to selected competitors. Also included are quantitative analyses of the company's financial statements, extensive ratio analyses ...

  • Industries : Hospitality, Hospitality
  • Countries : World, Norway
Norway Pharmaceuticals and Healthcare Report Q1 2016

Norway Pharmaceuticals and Healthcare Report Q1 2016

  • € 985
  • Industry report
  • January 2016
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Norway's 2016 fiscal stimulus is expected to be positive in terms of supporting thepharmaceutical and healthcare sector growth trajectory Over the long term, ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Targovax AS - Product Pipeline Review - 2015

Targovax AS - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • December 2015
  • by Global Markets Direct

Targovax AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Targovax AS - Product Pipeline Review - 2015’, provides an overview of the Targovax AS’s pharmaceutical research and ...

  • Industries : Research and Development, Pathology, Biological Therapy
  • Countries : World, Norway, United States
Industrial Construction in Norway to 2019: Market Forecast

Industrial Construction in Norway to 2019: Market Forecast

  • € 760
  • Industry report
  • December 2015
  • by Timetric

Synopsis Timetric’s 'Industrial Construction in Norway to 2019: Market Forecast' contains detailed historic and forecast market value data for the industrial construction industry, including a breakdown ...

  • Industries : Construction, Nonresidential Construction, Pharmaceutical
  • Countries : Norway, Europe
Vaccibody AS - Product Pipeline Review - 2015

Vaccibody AS - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • November 2015
  • by Global Markets Direct

Vaccibody AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Vaccibody AS - Product Pipeline Review - 2015’, provides an overview of the Vaccibody AS’s pharmaceutical research ...

  • Industries : Biopharmaceutical
  • Countries : Norway
Vitamins and Dietary Supplements in Norway

Vitamins and Dietary Supplements in Norway

  • € 800
  • Industry report
  • November 2015
  • by Euromonitor International

The media plays a huge role in the way that vitamins and dietary supplements are consumed in Norway, with this having had a negative effect over the last three years. Norwegian consumers spend a lot of ...

  • Industries : Healthcare
  • Countries : Norway
Chemical and Pharmaceutical Plants Construction in Norway to 2019: Market Databook

Chemical and Pharmaceutical Plants Construction in Norway to 2019: Market Databook

  • € 400
  • Industry report
  • November 2015
  • by Timetric

Synopsis Timetric’s 'Chemical and Pharmaceutical Plants Construction in Norway to 2019: Market Databook' contains detailed historic and forecast market value data for the chemical and pharmaceutical ...

  • Industries : Pharmaceutical
  • Countries : Norway
Weifa AS in Consumer Health (Norway)

Weifa AS in Consumer Health (Norway)

  • € 115
  • Industry report
  • November 2015
  • by Euromonitor International

Weifa plans to solidify its position in the OTC category in Norway by maintaining its lead in analgesics and becoming a top three player in cough, cold and allergy (hay fever) remedies through the continued ...

  • Industries : Drug and Medication, Healthcare, Over-The-Counter Drug, Pharmaceutical
  • Countries : Norway
Analgesics in Norway

Analgesics in Norway

  • € 825
  • Industry report
  • November 2015
  • by Euromonitor International

Media reports on the dangers of various analgesics played a key role in the performance of the different categories in 2015. Most notable were the various feelings expressed against ibuprofen, these contributing ...

  • Industries : Drug and Medication
  • Countries : Norway
Takeda Nycomed AS in Consumer Health (Norway)

Takeda Nycomed AS in Consumer Health (Norway)

  • € 115
  • Industry report
  • November 2015
  • by Euromonitor International

Takeda aims to maintain its position in Norway as a producer and distributor of good quality products, primarily within vitamins and dietary supplements, as well as an exporter of calcium tablets to ove ...

  • Industries : Healthcare, Vitamin and Supplement, Vitamin and Supplement
  • Countries : Norway
NRT Smoking Cessation Aids in Norway

NRT Smoking Cessation Aids in Norway

  • € 800
  • Industry report
  • November 2015
  • by Euromonitor International

NRT smoking cessation aids in 2015 continued to be influenced by various anti-smoking regulations, pricing and social stigma. Smoking continued to be illegal in public and work places, while the average ...

  • Industries : Drug and Medication
  • Countries : Norway
Norway Pharmaceuticals and Healthcare Report Q4 2015

Norway Pharmaceuticals and Healthcare Report Q4 2015

  • € 985
  • Industry report
  • September 2015
  • by Business Monitor International

Includes 3 FREE quarterly updates BMI View: Norway's pharmaceuticals and healthcare markets will continue to expand over the nextdecade, with patented medicines to continue to account for the majority ...

  • Industries : Pharmaceutical, Healthcare
  • Countries : Norway
Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts

Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • € 490
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Insulin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook for insulin in Norway. ...

  • Industries : Pathology, Drug and Medication, Pharmaceutical
  • Countries : Norway
Vitamin and Provitamin Market in Norway to 2019 - Market Size, Development, and Forecasts

Vitamin and Provitamin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • € 490
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Vitamin and Provitamin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook fo ...

  • Industries : Vitamin and Supplement, Vitamin and Supplement, Functional Food, Pharmaceutical
  • Countries : Norway, Europe
Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts

Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts

  • € 490
  • Industry report
  • August 2015
  • by Global Research & Data Services

The industry report Penicillin and Streptomycin Market in Norway to 2019 - Market Size, Development, and Forecasts offers the most up-to-date market data on the actual market situation, and future outlook ...

  • Industries : Drug and Medication
  • Countries : Norway
PCI Biotech AS - Product Pipeline Review - 2015

PCI Biotech AS - Product Pipeline Review - 2015

  • € 1 200
  • Company report
  • July 2015
  • by Global Markets Direct

PCI Biotech AS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘PCI Biotech AS - Product Pipeline Review - 2015’, provides an overview of the PCI Biotech AS’s pharmaceutical research ...

  • Industries : Biotechnology, Pathology
  • Countries : Norway
Vitamins & Minerals in Norway (2015) – Market Sizes

Vitamins & Minerals in Norway (2015) – Market Sizes

  • € 450
  • Industry report
  • June 2015
  • by Mintel

Vitamins & Minerals in Norway by Mintel Market Sizes provides you with annual year-end market size data, most recently updated in 2015. This market covers single/dual, multi-vitamins and minerals. It excludes ...

  • Industries : Retail, Vitamin and Supplement, Vitamin and Supplement
  • Countries : Norway
Physician Views: Will patient switching studies support biosimilar adoption?

Physician Views: Will patient switching studies support biosimilar adoption?

  • € 556
  • Industry report
  • June 2015
  • by Firstword Pharma

Europe's first biosimilar monoclonal antibody – Celltrion and Hospira's biosimilar Remicade product Inflectra/Remsima – is approaching its second year anniversary, following approval in the second ...

  • Industries : Biopharmaceutical
  • Countries : Norway
About 300 reports

Download Unlimited Documents from Trusted Public Sources

Fish Industry in Norway and Europe

  • February 2016
    12 pages
  • Fish  

    Anti-Infective  

    Aquaculture  

  • Norway  

    Europe  

View report >

Annual Report, 2016

January 2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.